Symbols / ABCL Stock $4.05 -0.74% AbCellera Biologics Inc.

Healthcare • Biotechnology • Canada • NMS
ABCL (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
About

AbCellera Biologics Inc. engages in discovering and developing antibody-based medicines for indications with unmet medical need in the United States. Its lead product is ABCL635, an non-hormonal medicine, which is in Phase 2 clinical trial to treat moderate-to-severe vasomotor symptoms; and ABCL575, a fully human, half-life extended monoclonal antibody, which is in in a Phase 1 clinical trial for treating T-cell-mediated autoimmune conditions, such as atopic dermatitis. The company has a research collaboration and license agreement with Eli Lilly and Company; AbbVie Inc.; and partnership agreement with Viking Global Investors & ArrowMark Partners and Biogen Inc. AbCellera Biologics Inc. was incorporated in 2012 and is headquartered in Vancouver, Canada.

Stock Fundamentals
Scroll to Statements
Market Cap 1.23B Enterprise Value 846.29M Income -146.41M Sales 75.13M Book/sh 3.22 Cash/sh 1.76
Dividend Yield — Payout 0.00% Employees 562 IPO — P/E — Forward P/E -5.17
PEG — P/S 16.34 P/B 1.26 P/C — EV/EBITDA -4.34 EV/Sales 11.27
Quick Ratio 10.07 Current Ratio 11.32 Debt/Eq 14.81 LT Debt/Eq — EPS (ttm) -0.49 EPS next Y -0.78
EPS Growth — Revenue Growth 7.88% Earnings 2026-05-11 ROA -9.99% ROE -14.47% ROIC —
Gross Margin -148.68% Oper. Margin -63.72% Profit Margin -194.88% Shs Outstand 303.16M Shs Float 206.79M Short Float 21.49%
Short Ratio 18.79 Short Interest — 52W High 6.51 52W Low 1.94 Beta 0.85 Avg Volume 3.51M
Volume 8.14M Target Price $9.43 Recom Strong_buy Prev Close $4.08 Price $4.05 Change -0.74%
Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$9.43
Mean price target
2. Current target
$4.05
Latest analyst target
3. DCF / Fair value
$-10.45
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$4.05
Low
$7.00
High
$12.00
Mean
$9.43

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-04-10 init Jones Trading — → Buy $11
2025-11-07 down Leerink Partners Outperform → Market Perform $4
2025-08-08 main Stifel Buy → Buy $7
2025-07-14 main Keybanc Overweight → Overweight $10
2025-05-16 main Truist Securities Buy → Buy $10
2025-05-09 main Stifel Buy → Buy $8
2025-04-16 main Keybanc Overweight → Overweight $5
2025-03-03 reit Benchmark Hold → Hold —
2025-02-28 main Stifel Buy → Buy $10
2025-01-08 main Keybanc Overweight → Overweight $4
2024-11-05 reit Benchmark — → Hold —
2024-11-05 reit Stifel Buy → Buy $12
2024-08-20 down Benchmark Buy → Hold —
2024-07-11 main Keybanc Overweight → Overweight $5
2024-05-08 main Keybanc Overweight → Overweight $7
2024-02-22 up Benchmark Hold → Buy —
2024-02-21 main Stifel Buy → Buy $17
2023-12-05 init Keybanc — → Overweight $6
2023-08-31 main Benchmark Buy → Buy $12
2023-08-04 main Goldman Sachs Buy → Buy $24
News
RSS: Latest ABCL news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-02-27 THERMOPYLAE HOLDINGS, LTD. Beneficial Owner of more than 10% of a Class of Security — 38,000 $3.44 $130,720
2026-02-27 BOOTH ANDREW Chief Financial Officer — 42,600 $3.42 $145,692
2026-02-26 THERMOPYLAE HOLDINGS, LTD. Beneficial Owner of more than 10% of a Class of Security — 177,457 $3.27 $580,284
2025-12-18 THERMOPYLAE HOLDINGS, LTD. Beneficial Owner of more than 10% of a Class of Security — 225,000 $0.00 $0
2025-11-26 MONTALBANO JOHN S. Director — 50,000 $3.57 $178,460
2025-03-11 THERMOPYLAE HOLDINGS, LTD. Beneficial Owner of more than 10% of a Class of Security — 343,631 $2.16 $742,243
2025-03-10 MONTALBANO JOHN S. Director — 25,000 $2.30 $57,500
2025-03-06 MONTALBANO JOHN S. Director — 60,000 $2.34 $140,568
2024-12-04 THERMOPYLAE HOLDINGS, LTD. Beneficial Owner of more than 10% of a Class of Security — 286,000 $0.00 $0
2024-11-25 HANSEN CARL L.G. Chief Executive Officer — 56,125 $2.70 $151,538
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
75.13
+160.56%
28.83
-24.17%
38.02
-92.17%
485.42
Operating Revenue
75.13
+160.56%
28.83
-24.17%
38.02
-92.17%
485.42
Cost Of Revenue
—
0.00
0.00
-100.00%
66.44
Reconciled Cost Of Revenue
—
0.00
0.00
-100.00%
61.18
Gross Profit
—
28.83
-24.17%
38.02
-90.92%
418.99
Operating Expense
278.34
-15.65%
329.98
+26.39%
261.08
+36.03%
191.92
Research And Development
186.83
+11.70%
167.26
-4.78%
175.66
+62.83%
107.88
Selling General And Administration
83.23
-2.64%
85.49
+13.72%
75.18
+12.62%
66.75
Selling And Marketing Expense
—
12.78
-9.88%
14.18
+25.82%
11.27
General And Administrative Expense
—
72.71
+19.20%
61.00
+9.94%
55.48
Other Gand A
—
72.71
+19.20%
61.00
+9.94%
55.48
Other Operating Expenses
-13.89
-1.98%
-13.62
+3.78%
-14.15
-34.12%
-10.55
Total Expenses
278.34
-15.65%
329.98
+26.39%
261.08
+1.05%
258.36
Operating Income
-203.21
+32.52%
-301.15
-35.01%
-223.05
-198.23%
227.06
Total Operating Income As Reported
-217.10
+31.03%
-314.77
-32.70%
-237.21
-209.56%
216.51
EBITDA
-174.39
+14.58%
-204.15
-6.24%
-192.16
-173.86%
260.17
Normalized EBITDA
-174.39
+14.58%
-204.15
-6.24%
-192.16
-173.86%
260.17
Reconciled Depreciation
28.82
-70.29%
97.00
+213.97%
30.89
-6.67%
33.10
EBIT
-203.21
+32.52%
-301.15
-35.01%
-223.05
-198.23%
227.06
Total Unusual Items
—
—
—
—
Total Unusual Items Excluding Goodwill
—
—
—
—
Net Income
-146.41
+10.10%
-162.86
-11.24%
-146.40
-192.35%
158.52
Pretax Income
-177.59
+11.38%
-200.40
-15.15%
-174.03
-172.79%
239.10
Net Non Operating Interest Income Expense
28.33
-26.37%
38.47
-8.93%
42.25
+162.75%
16.08
Interest Expense Non Operating
—
—
—
4.04
Net Interest Income
28.33
-26.37%
38.47
-8.93%
42.25
+162.75%
16.08
Interest Expense
—
—
—
4.04
Interest Income Non Operating
28.33
-26.37%
38.47
-8.93%
42.25
+162.75%
16.08
Interest Income
28.33
-26.37%
38.47
-8.93%
42.25
+162.75%
16.08
Other Income Expense
-2.71
-104.35%
62.28
+819.10%
6.78
+267.52%
-4.04
Other Non Operating Income Expenses
-2.71
-104.35%
62.28
+819.10%
6.78
+267.52%
-4.04
Gain On Sale Of Security
—
—
—
—
Tax Provision
-31.18
+16.93%
-37.54
-35.85%
-27.63
-134.29%
80.58
Tax Rate For Calcs
0.00
-6.26%
0.00
+17.98%
0.00
-52.89%
0.00
Tax Effect Of Unusual Items
0.00
0.00
0.00
0.00
Net Income Including Noncontrolling Interests
-146.41
+10.10%
-162.86
-11.24%
-146.40
-192.35%
158.52
Net Income From Continuing Operation Net Minority Interest
-146.41
+10.10%
-162.86
-11.24%
-146.40
-192.35%
158.52
Net Income From Continuing And Discontinued Operation
-146.41
+10.10%
-162.86
-11.24%
-146.40
-192.35%
158.52
Net Income Continuous Operations
-146.41
+10.10%
-162.86
-11.24%
-146.40
-192.35%
158.52
Normalized Income
-146.41
+10.10%
-162.86
-11.24%
-146.40
-192.35%
158.52
Net Income Common Stockholders
-146.41
+10.10%
-162.86
-11.24%
-146.40
-192.35%
158.52
Otherunder Preferred Stock Dividend
—
—
—
0.00
Diluted EPS
-0.49
+10.91%
-0.55
-7.84%
-0.51
-202.00%
0.50
Basic EPS
-0.49
+10.91%
-0.55
-7.84%
-0.51
-191.07%
0.56
Basic Average Shares
298.71
+1.49%
294.33
+1.78%
289.17
+1.44%
285.06
Diluted Average Shares
298.71
+1.49%
294.33
+1.78%
289.17
-8.15%
314.83
Diluted NI Availto Com Stockholders
-146.41
+10.10%
-162.86
-11.24%
-146.40
-192.35%
158.52
Depreciation Amortization Depletion Income Statement
22.17
-75.60%
90.85
+272.41%
24.39
-12.38%
27.84
Depreciation And Amortization In Income Statement
22.17
-75.60%
90.85
+272.41%
24.39
-12.38%
27.84
Depreciation Income Statement
—
—
—
27.84
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
1,356.95
-0.26%
1,360.55
-8.57%
1,488.09
-3.43%
1,540.91
Current Assets
728.23
-3.08%
751.37
-13.83%
871.99
-14.97%
1,025.49
Cash Cash Equivalents And Short Term Investments
533.83
-14.67%
625.61
-17.75%
760.59
-14.20%
886.49
Cash And Cash Equivalents
128.51
-17.79%
156.32
+17.26%
133.32
-65.51%
386.54
Cash Equivalents
29.30
+0.34%
29.20
—
—
Cash Financial
99.30
-21.87%
127.10
—
—
Other Short Term Investments
405.31
-13.63%
469.29
-25.18%
627.26
+25.47%
499.95
Receivables
153.40
+66.50%
92.13
+43.10%
64.38
-37.74%
103.41
Accounts Receivable
58.29
+73.41%
33.62
+9.89%
30.59
-20.74%
38.59
Taxes Receivable
55.70
+109.90%
26.53
-21.48%
33.79
-47.87%
64.82
Loans Receivable
39.41
+23.24%
31.98
0.00
—
Inventory
6.34
0.00
-100.00%
1.11
-27.74%
1.53
Raw Materials
6.34
0.00
-100.00%
1.11
-27.74%
1.53
Prepaid Assets
—
—
—
9.06
Restricted Cash
25.00
+0.00%
25.00
+0.00%
25.00
+0.00%
25.00
Other Current Assets
9.67
+12.10%
8.63
-60.82%
22.02
+142.92%
9.06
Total Non Current Assets
628.72
+3.21%
609.18
-1.12%
616.11
+19.54%
515.42
Net PPE
428.00
+25.72%
340.43
+18.33%
287.70
+32.42%
217.25
Gross PPE
485.62
+27.74%
380.15
+19.43%
318.30
+35.03%
235.73
Accumulated Depreciation
-57.61
-45.06%
-39.72
-29.76%
-30.61
-65.67%
-18.48
Properties
0.00
0.00
0.00
0.00
Land And Improvements
53.41
+0.00%
53.41
+0.00%
53.41
+0.00%
53.41
Buildings And Improvements
193.16
+9.87%
175.81
+300.04%
43.95
+286.82%
11.36
Machinery Furniture Equipment
—
—
3.52
-57.64%
8.30
Other Properties
239.05
+58.38%
150.94
+2.67%
147.01
+20.41%
122.09
Leases
—
122.89
+66.20%
73.94
+82.28%
40.57
Goodwill And Other Intangible Assets
86.19
-4.15%
89.92
-46.55%
168.23
-6.18%
179.31
Goodwill
47.81
+0.00%
47.81
+0.00%
47.81
+0.00%
47.81
Other Intangible Assets
38.38
-8.86%
42.11
-65.03%
120.42
-8.42%
131.50
Investments And Advances
62.58
-23.96%
82.30
+24.81%
65.94
-9.08%
72.52
Long Term Equity Investment
62.58
-23.96%
82.30
+24.81%
65.94
-9.08%
72.52
Other Investments
—
—
—
—
Non Current Deferred Assets
—
—
—
—
Non Current Deferred Taxes Assets
—
—
—
—
Non Current Prepaid Assets
—
—
—
—
Other Non Current Assets
51.95
-46.19%
96.54
+2.43%
94.24
+103.41%
46.33
Total Liabilities Net Minority Interest
390.05
+28.11%
304.47
-9.32%
335.78
+9.15%
307.63
Current Liabilities
64.31
-16.06%
76.61
-35.63%
119.01
+0.59%
118.32
Payables And Accrued Expenses
35.98
-29.18%
50.81
-41.45%
86.78
+2.29%
84.84
Payables
25.23
-40.55%
42.44
-46.34%
79.08
+0.88%
78.39
Accounts Payable
25.23
-26.56%
34.35
+20.09%
28.60
+92.90%
14.83
Other Payable
—
8.09
-83.98%
50.48
-20.58%
63.56
Current Accrued Expenses
10.76
+28.42%
8.38
+8.67%
7.71
+19.41%
6.45
Total Tax Payable
—
—
—
0.00
Income Tax Payable
—
—
—
0.00
Current Debt And Capital Lease Obligation
5.82
+25.84%
4.62
-24.96%
6.16
+10.30%
5.58
Current Capital Lease Obligation
5.82
+25.84%
4.62
-24.96%
6.16
+10.30%
5.58
Current Deferred Liabilities
22.51
+6.28%
21.18
-18.76%
26.07
-6.55%
27.90
Current Deferred Revenue
22.51
+6.28%
21.18
-18.76%
26.07
-6.55%
27.90
Other Current Liabilities
—
—
—
—
Total Non Current Liabilities Net Minority Interest
325.74
+42.96%
227.86
+5.12%
216.76
+14.50%
189.31
Long Term Debt And Capital Lease Obligation
137.40
+126.20%
60.74
-14.71%
71.22
-7.11%
76.67
Long Term Capital Lease Obligation
137.40
+126.20%
60.74
-14.71%
71.22
-7.11%
76.67
Tradeand Other Payables Non Current
—
0.00
-100.00%
4.91
-69.40%
16.05
Non Current Deferred Liabilities
183.57
+14.77%
159.94
+18.72%
134.72
+44.10%
93.50
Non Current Deferred Revenue
174.45
+16.39%
149.89
+43.98%
104.11
+72.60%
60.32
Non Current Deferred Taxes Liabilities
9.12
-9.32%
10.05
-67.16%
30.61
-7.73%
33.18
Other Non Current Liabilities
4.77
-33.49%
7.17
+21.39%
5.91
+91.38%
3.09
Stockholders Equity
966.90
-8.44%
1,056.08
-8.35%
1,152.32
-6.56%
1,233.28
Common Stock Equity
966.90
-8.44%
1,056.08
-8.35%
1,152.32
-6.56%
1,233.28
Capital Stock
802.34
+3.24%
777.17
+3.18%
753.20
+2.56%
734.37
Common Stock
802.34
+3.24%
777.17
+3.18%
753.20
+2.56%
734.37
Share Issued
300.60
+1.64%
295.76
+1.70%
290.82
+1.39%
286.85
Ordinary Shares Number
300.60
+1.64%
295.76
+1.70%
290.82
+1.39%
286.85
Additional Paid In Capital
198.28
+19.19%
166.36
+37.43%
121.05
+63.32%
74.12
Retained Earnings
-29.48
-125.21%
116.93
-58.21%
279.79
-34.35%
426.19
Gains Losses Not Affecting Retained Earnings
-4.23
+3.29%
-4.38
-154.53%
-1.72
-23.65%
-1.39
Other Equity Adjustments
-4.23
+3.29%
-4.38
-154.53%
-1.72
-23.65%
-1.39
Total Equity Gross Minority Interest
966.90
-8.44%
1,056.08
-8.35%
1,152.32
-6.56%
1,233.28
Total Capitalization
966.90
-8.44%
1,056.08
-8.35%
1,152.32
-6.56%
1,233.28
Working Capital
663.92
-1.61%
674.76
-10.39%
752.97
-17.00%
907.17
Invested Capital
966.90
-8.44%
1,056.08
-8.35%
1,152.32
-6.56%
1,233.28
Total Debt
143.22
+119.11%
65.36
-15.53%
77.38
-5.93%
82.26
Capital Lease Obligations
143.22
+119.11%
65.36
-15.53%
77.38
-5.93%
82.26
Net Tangible Assets
880.72
-8.84%
966.16
-1.82%
984.09
-6.63%
1,053.97
Tangible Book Value
880.72
-8.84%
966.16
-1.82%
984.09
-6.63%
1,053.97
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
-131.29
-20.95%
-108.56
-147.41%
-43.88
-115.82%
277.36
Cash Flow From Continuing Operating Activities
-131.29
-20.95%
-108.56
-147.41%
-43.88
-115.82%
277.36
Net Income From Continuing Operations
-146.41
+10.10%
-162.86
-11.24%
-146.40
-192.35%
158.52
Depreciation Amortization Depletion
28.82
-70.29%
97.00
+213.97%
30.89
-6.67%
33.10
Depreciation
25.09
+34.27%
18.69
-2.97%
19.26
+35.50%
14.21
Amortization Cash Flow
3.73
-95.23%
78.31
+572.96%
11.64
-38.40%
18.89
Depreciation And Amortization
28.82
-70.29%
97.00
+213.97%
30.89
-6.67%
33.10
Amortization Of Intangibles
3.73
-95.23%
78.31
+572.96%
11.64
-38.40%
18.89
Other Non Cash Items
1.20
+101.42%
-84.44
-1360.56%
-5.78
-189.86%
6.43
Stock Based Compensation
55.79
-17.44%
67.58
+5.29%
64.18
+29.71%
49.48
Deferred Tax
—
—
1.96
+192.72%
-2.11
Deferred Income Tax
—
—
1.96
+192.72%
-2.11
Change In Working Capital
-70.69
-173.55%
-25.84
-295.41%
13.22
-55.66%
29.82
Change In Receivables
-55.62
+25.95%
-75.12
-63.54%
-45.93
-143.15%
106.46
Changes In Account Receivables
-55.62
+25.95%
-75.12
-63.54%
-45.93
-102.21%
-22.71
Change In Payables And Accrued Expense
3.46
-67.49%
10.63
+170.41%
-15.10
-621.30%
-2.09
Change In Accrued Expense
—
—
—
-3.16
Change In Payable
—
—
-15.10
+82.75%
-87.54
Change In Account Payable
—
—
-15.10
-1516.89%
1.07
Change In Other Working Capital
-35.68
-209.14%
32.69
-41.64%
56.01
+176.55%
-73.16
Change In Other Current Assets
17.15
+188.01%
5.95
-67.38%
18.25
+1427.49%
-1.38
Change In Other Current Liabilities
—
—
—
-3.06
Investing Cash Flow
87.75
-27.72%
121.41
+154.91%
-221.11
+37.30%
-352.62
Cash Flow From Continuing Investing Activities
87.75
-27.72%
121.41
+154.91%
-221.11
+37.30%
-352.62
Net PPE Purchase And Sale
-42.77
+45.44%
-78.40
-1.88%
-76.95
-8.90%
-70.66
Purchase Of PPE
-42.77
+45.44%
-78.40
-1.88%
-76.95
-8.90%
-70.66
Capital Expenditure
-42.77
+45.44%
-78.40
-1.88%
-76.95
-5.90%
-72.66
Net Investment Purchase And Sale
52.94
-71.19%
183.72
+217.94%
-155.78
+42.46%
-270.72
Purchase Of Investment
-453.14
+40.77%
-765.09
+28.28%
-1,066.72
-36.52%
-781.35
Sale Of Investment
506.07
-46.66%
948.81
+4.16%
910.94
+78.39%
510.63
Net Business Purchase And Sale
-7.14
+63.63%
-19.63
-43.36%
-13.69
+46.69%
-25.68
Purchase Of Business
-7.14
+63.63%
-19.63
-43.36%
-13.69
+46.69%
-25.68
Net Intangibles Purchase And Sale
—
0.00
+100.00%
-0.56
+72.00%
-2.00
Purchase Of Intangibles
—
0.00
+100.00%
-0.56
+72.00%
-2.00
Net Other Investing Changes
54.61
+52.94%
35.71
+41.08%
25.31
+54.02%
16.43
Financing Cash Flow
14.08
+10.28%
12.77
+23.30%
10.36
+736.12%
-1.63
Cash Flow From Continuing Financing Activities
14.08
+10.28%
12.77
+23.30%
10.36
+736.12%
-1.63
Net Issuance Payments Of Debt
—
—
11.59
+376.56%
2.43
Issuance Of Debt
—
—
11.59
+320.69%
2.75
Repayment Of Debt
—
—
—
-0.32
Long Term Debt Issuance
—
—
11.59
+320.69%
2.75
Long Term Debt Payments
—
—
—
-0.32
Net Long Term Debt Issuance
—
—
11.59
+376.56%
2.43
Net Short Term Debt Issuance
—
—
—
—
Net Common Stock Issuance
—
—
—
0.00
Proceeds From Stock Option Exercised
—
—
—
—
Net Other Financing Charges
14.08
+10.28%
12.77
+23.30%
10.36
+736.12%
-1.63
Changes In Cash
-29.46
-214.99%
25.62
+110.06%
-254.63
-231.15%
-76.89
Effect Of Exchange Rate Changes
1.10
+141.92%
-2.62
-544.31%
0.59
+106.14%
-9.60
Beginning Cash Position
183.62
+14.32%
160.61
-61.27%
414.65
-17.26%
501.14
End Cash Position
155.25
-15.45%
183.62
+14.32%
160.61
-61.27%
414.65
Free Cash Flow
-174.07
+6.89%
-186.95
-54.73%
-120.82
-159.02%
204.70
Change In Income Tax Payable
—
—
—
-88.61
Change In Tax Payable
—
—
—
-88.61
Common Stock Issuance
—
—
—
0.00
Dividends Received CFI
30.11
0.00
0.00
—
Issuance Of Capital Stock
—
—
—
0.00
Net Preferred Stock Issuance
—
—
—
0.00
Preferred Stock Issuance
—
—
—
0.00
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category